Alzamend Neuro is trading 5.6% up today at $1.33 as micro-cap volatility and a risk-on market environment drive gains despite a lack of company-specific news.
- No fresh regulatory filings, press releases, or analyst actions have been reported for the company today.
- The upward move aligns with a generally positive day for major U.S. indices, even as the broader biotech sector faces some pressure.